Correlation between Insulin antibodyand HbA1c in Diabetes Mellitus
DOI:
https://doi.org/10.32792/utq/utjsci/v11i2.1242Keywords:
: Insulin antibody , HbA1c , poor glycemic controlAbstract
Insulin antibodies (INAs) are found in both types of diabetic patients and have low binding capacity and high affinity leading to hypoglycemia or hyperglycemia in type II patients taking insulin, which differs from the insulin antibodies found in type I that contain a high capacity of insulin binding and low affinity. This work aims to detect the levels of insulin antibodies and HbA1c in diabetic patients, and find the correlation between them and its potential role in glucose control. The study involved 60 patients with diabetes, divided into two groups type I and type II, each group containing 30 patients, in addition to 30 healthy individuals as a control group. High-performance liquid chromatography in a D-10 analyzer was used to measure HbA1c while ELISA was used to measure INAs in control and patients .Results: The current finding showed significant an elevated mean levels of HbA1c and INAs in both of patients groups compare to healthy, and there was non-significant weak positive correlation between them (R= 0.107 , P= 0.4 ).Together, elevated levels of HbA1c and INA, and the positive correlation between their levels, provide evidence of the effect of insulin antibodies on glycemic control and the effects of HbA1c levels in patients with diabetes.
Received: 2024-05-04
Revised:2024-05-24
Accepted: 2024-06-03
References
M.S.Rahman, K.S.Hossain, S. Das, S.Kundu, E.O. Adegoke, M.A.Rahman, et al., "Role of Insulin in Health and Disease: An Update". Int J Mol Sci. Vol.22, No 12, pp. 6403, 2021.
G.F. Lewis, and P.L. Brubaker "The discovery of insulin revisited: Lessons for the modern era". J. Clin. Investig. ;Vol.131,pp. e142239,2021.
A.G. Ziegler, M.Rewers, O.Simell, T.Simell, J. Lempainen, A. Steck, et al. "Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children". JAMA. Vol. 309, No. 23,pp. 2473–2479,2013 .
T.W. Van Haeften: "Clinical significance of insulin antibodies in insulin-treated diabetic patients". Diabetes Care,Vol. 12,pp. 641–648, 1989
N. Hattori, M. R. Duhita, A. Mukai , M. Matsueda ,and A. Shimatsu . "Development of insulin antibodies and changes in titers over a long-term period in patients with type 2 diabetes." Clinica Chimica Acta .Vol. 433, pp. 135-138, 2014.
S. Chen, H. Chen, Y. Jiang, X. Zheng, M. Zhang, T .Yang and Gu "Association of subclass distribution of insulin antibody with glucose control in insulin-treated type 2 diabetes mellitus: a retrospective observational study" Front. Endocrinol. Vol. 14,PP.1141414,2023
S. Champaneri, "Insulin Antibodies." Johns Hopkins Diabetes Guide, Johns Hopkins Guides, 2017.
X. Hu and F. Chen "Exogenous insulin antibody syndrome (EIAS): a clinical syndrome associated with insulin antibodies induced by exogenous insulin in diabetic patients". Endocr Connect. Vol.7,No.1,pp. R47-R55, 2018.
D. M. Nathan, M.B. Davidson, R.A . DeFronzo, R. J. Heine, R. R. Henry, R .Pratley, et al. "Impaired fasting glucose and impaired glucose tolerance: implications for care". Diabetes Care. Vol.30,No.3, pp.753–759, 2007.
J. Zhu L. Yuan, W.J. Ni, Y.Luo, and J.H. Ma. "Association of Higher Circulating Insulin Antibody with Increased Mean Amplitude Glycemic Excursion in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional, Retrospective Case-Control Study". J Diabetes Res. Vol.18,pp. 7304140, 2019.
R.R Little, C.L. Rohlfing and D.B Sacks. "Status of hemoglobin A1c measurement and goals for improvement: From chaos to order for improving diabetes care". Clin. Chem. Vol.57pp. 205–.
A.M.Albadri and J.K.Al_Diwan. "Effect of carbohydrate intake on glycemic control among adult patients with type 2 diabetes mellitus attending Diabetes and Endocrine Diseases Center in Babe"l, 2022. Med J Babylon,Vol.20,pp.41-47, 2023.
K.Z. Chako, H.rPhillipo, E.i .Mafuratidze, and D. T. Zhou,, "Significant Differences in the Prevalence of Elevated HbA1c Levels for Type I and Type II Diabetics Attending the Parirenyatwa Diabetic Clinic in Harare, Zimbabwe", Chinese Journal of Biology, vol. 2014, Article ID 672980,No, 5, 2014.
M. S. Al-Fayyadh, K. H. Ismael and A. J.R. Al-Saady . "Study of insulin resistance, cortisol hormone and some biochemical parameters in Iraqi type 2 diabetic patients" .University of Thi-Qar Journal of Science, Vol. 10,No. 2, pp. 68–72, 2023.
H.A.Thijail, and H.M .Mousa. "Comparative Study Of Some Immunological Aspects Between Type I And Type II Diabetic Mellitus In Iraqi Patients Of Thi-Qar Province."European Journal of Molecular & Clinical Medicine,Vol. 7No. 1,pp. 3537-3546, 2020.
T. Segal, E. A. Webb, R. Viner. C. Pusey, G. Wild, and J. Allgrove. "Severe insulin resistance secondary to insulin antibodies: successful treatment with the immunosuppressantMMF". Pediatr Diabetes, Vol. 9,No.,pp. 250–254, 2008.
N. Jassam, N. Amin, P. Holland, R. K .Semple , D. J.Halsall , G. Wark , and J. H. Barth "Analytical and clinical challenges in a patient with concurrent type 1 diabetes, subcutaneous insulin resistance and insulin autoimmune syndrome". Endocrinol Diabetes Metab Case Rep ,Vol. 2014,pp. 130086, 2014.
J.B Hao, S. Imam, P. Dar, M. Alfonso-Jaume , N.Elnagar ,and J. C.Jaume . "Extreme insulin resistance from insulin antibodies (not insulin receptor antibodies) successfully treated with combination immunosuppressivetherapy". DiabetesCare ,Vol.40,pp. e19–e20, 2017.
T. Takeuchi, Y.Hirota, Y. Nakagawa, A. Matsuoka, T .Hama .guchi, Y. Okada, et al. "Glycated albumin (GA) and theGA/HbA1c ratio are higher in diabetic patients positive for insulin antibodies with high binding capacity and low affinity". Diabetol Int. Vol.13,No.1,pp. 226-231, 2021.
T.Bistritzer, J. Sack, R. Theodor, L ..Weissglass, I. Ben-Bassat, and M Lahav. "Correlation between HbA1c, purified insulins, diabetic control, and insulin antibodies in diabetic children". HormRes,Vol.20,No.3,pp. 178-185, 1984.
Downloads
Published
License
Copyright (c) 2024 University of Thi-Qar Journal of Science
This work is licensed under a Creative Commons Attribution 4.0 International License.
